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Prognostic Value of Early Magnetic Resonance Imaging in Dogs
after Traumatic Brain Injury: 50 Cases
E. Beltran, S.R. Platt, J.F. McConnell, R. Dennis, D.A. Keys, and L. De Risio
Background: The prognostic value of early magnetic resonance imaging (MRI) in dogs after traumatic brain injury
(TBI) remains unclear.
Objectives: Determine whether MRI findings are associated with prognosis after TBI in dogs.
Animals: Fifty client-owned dogs.
Methods: Retrospective study of dogs with TBI that underwent 1.5T MRI within 14 days after head trauma. MRI
evaluators were blinded to the clinical presentation, and all images were scored based on an MRI grading system (Grade I
[normal brain parenchyma] to Grade VI [bilateral lesions affecting the brainstem with or without any lesions of lesser
grade]). Skull fractures, percentage of intraparenchymal lesions, degree of midline shift, and type of brain herniation were
evaluated. MGCS was assessed at presentation. The presence of seizures was recorded. Outcome was assessed at 48 h
(alive or dead) and at 3, 6, 12, and 24 months after TBI.
Results: Sixty-six percent of the dogs had abnormal MRI findings. MRI grade was negatively correlated (P < .001)
with MGCS. A significant negative correlation of MRI grade, degree of midline shift, and percentage of intraparenchymal
lesions with follow-up scores was identified. The MGCS was lower in dogs with brain herniation (P = .0191). Follow-up
scores were significantly lower in dogs that had brain herniation or skull fractures. The possibility of having seizures was
associated with higher percentage of intraparenchymal lesions (P = 0.0054) and 10% developed PTE.
Conclusions and Clinical Importance: Significant associations exist between MRI findings and prognosis in dogs with
TBI. MRI can help to predict prognosis in dogs with TBI.
Key words: Dogs; MRI; Prognostic; Traumatic brain injury.
Traumatic brain injury (TBI) is defined as structuralinjury or physiological disruption of the brain
induced by an external force. In human medicine, TBI
is indicated clinically by the acute onset of at least one
of the following: a period of loss of or decreased
consciousness, alteration in mental status, neurologic
deficits, presence of an intracranial lesion, or some
combination of these.1 Not all the patients exposed to
head trauma will suffer from TBI.1 A recent single-
center retrospective study reported that up to 25% of
dogs with severe blunt trauma suffer from TBI.2 Dogs
with TBI are assessed clinically using the modified
Glasgow coma scale (MGCS), which evaluates 3 cate-
gories: motor activity, brainstem reflexes, and level of
consciousness.3,4 Each category is scored from 1 to 6
(lower score assigned to worse neurologic status), and
the category scores are added together to determine
the patient’s total modified Glasgow coma score
(Table 1). The MGCS total score ranges from 3 to 18,
with the lowest score representing the worst neurologic
status and the lowest probability of survival within the
first 48 hours after head trauma.4
Posttraumatic epilepsy (PTE) is among the most
common form of acquired epilepsy in humans.5 The
onset of seizures after TBI has been categorized into
immediate (<24 hours after TBI), early (within a week
after TBI), and late (>1 week after TBI) onset.5 Focal
brain lesions in the frontal, temporal and parietal
lobes, bilateral contusions, depressed fractures, midline
shift >5 mm, subdural hematomas, decreased brain
volume, intraparenchymal hemorrhage, and occurrence
of seizures within the first week after TBI are impor-
tant risk factors for PTE in humans.5–8 Traumatic
brain injury in dogs recently has been associated with
significant risk of developing PTE with an incidence
up to 6.8%.9,10 Moreover, the risk of developing PTE
increases with the severity of TBI.9,10
The role of neuroimaging in human patients with
TBI is still emerging.1 Currently, computed tomogra-
phy (CT) is the modality of choice as a diagnostic tool
for acute TBI.1 However, MRI (1.5 Tesla) has sensitiv-
ity superior to that of CT for small focal traumatic
intracranial lesions in patients with TBI and also
results in fewer artifacts when assessing the brain-
stem.11–13 Recent studies in humans have determined
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the value of MRI in patients with TBI.14–18 More
severe brain contusion has been associated with poorer
3-month outcome based on MRI in a recent prospec-
tive multicenter observational study in humans.17
To the best of the authors’ knowledge, the prognos-
tic value of early MRI after TBI in dogs has not been
studied previously. The aim of this study was to deter-
mine whether MRI findings are associated with prog-
nosis after TBI in dogs.
Material and Methods
Study Population and Clinical Evaluation
The medical records of all dogs presented to the Animal
Health Trust from April 2000 to August 2012 were reviewed.
Inclusion criteria were as follows: (1) TBI based on clinical his-
tory, (2) no known history of intracranial central nervous system
disease unrelated to the TBI, (3) neurologic examination docu-
mented in the medical record and MGCS recorded at presenta-
tion,3 (4) minimum follow-up of 48 hours, and (5) 1.5 T MRI
performed in the first 14 days after TBI.
Data retrieved from the medical records included signalment,
history, physical and neurologic examination findings at presenta-
tion, presence of seizures after TBI, treatment, and outcome. Sei-
zures were classified as immediate when the first seizure occurred
<24 hours after TBI, early when it occurred within a week after
TBI and late when it occurred >1 week after TBI.
Imaging Protocol and Analysis
Magnetic resonance imaging was performed using a 1.5 Tesla
scanner.a T2-weighted (T2W) fast spin echo (FSE) images were
acquired in dorsal, sagittal, and transverse planes. Additional
sequences included T2* gradient echo, T2-fluid attenuation inver-
sion recovery, and T1-weighted FSE sequences before and after
bolus administration of gadopentetate dimeglumineb at a dosage
of 0.1 mL/kg of body weight. Slice thickness ranged from 2 to
4 mm.
The MRI findings were graded by three of the authors (E.B.,
F.M., and R.D.) who were blinded to the clinical findings. Dis-
agreement was solved by consensus. Severity and location of
lesions were classified based on a modified MRI grading sys-
tem,19 as follows: Grade I—normal parenchyma; Grade II—
lesions only affecting the cerebral hemisphere, cerebellar paren-
chyma, or both without midline shift; Grade III—lesions only
affecting the cerebral hemisphere, cerebellar parenchyma, or both
and causing midline shift; Grade IV—lesions affecting corpus
callosum, thalamus, or basal nuclei with or without any of the
foregoing lesions of lesser grades; Grade V—unilateral lesions in
the brainstem with or without any of the foregoing lesions of les-
ser grades; Grade VI—bilateral lesions affecting the brainstem
with or without any of the foregoing lesions of lesser grades
(Fig 1).
The percentage of midline shift was calculated on transverse
T2W-FSE images. The midline shift was measured as the dis-
tance of maximum shift from the midline using commercial soft-
ware.c This value was multiplied by 100 and divided by the
distance from the midline to the convexity surface at the same
level to calculate the percentage of midline shift.
The type of brain herniation20 also was recorded as: herniation
through the foramen magnum, caudal transtentorial herniation
(CTH), rostral transtentorial herniation, subfalcine, and hernia-
tion through a fracture site (HFS). The extent of intraparenchy-
mal damage (lesion[s] size) was measured using the software and
recorded as 0, <25, 25–50, or >50% based on transverse, dorsal,
and sagittal T2W-FSE images. Skull fractures were classified as
open or closed, and depressed or nondepressed.
Outcome Measures
Short-term outcome was defined as survival or nonsurvival at
48 hours after TBI. Long-term outcome was assessed, when pos-
sible, at 3, 6, 12, and 24 months after TBI. Follow-up informa-
tion at 3, 6, 12, and 24 months was obtained by telephone
consultation with the owner, referring veterinarian, or both and
combined with information from medical records. The outcome
scale comprised 4 scores: (score 0) dead or euthanized because of
the severity of the clinical presentation; (score 1) poor recovery:
the dog had severe neurologic deficits or did not improve; (score
2) good recovery: the dog improved but still had visible mild neu-
rologic deficits, required antiepileptic medication, or both; (score
3) excellent recovery: the dog was considered normal and did not
require antiepileptic medication.
Statistical Analysis
Spearman correlation was used to test for correlations of
MGCS at presentation and follow-up at 3, 6, 12, and 24 months
with the following risk factors: MRI grade, intraparenchymal
lesion percentage, and percentage of midline shift. Mann-Whitney
U-tests were used to compare MGCS at presentation and follow-
up scores between various binomial (yes/no) risk factor groups
(presence of midline shift, brain herniation, brain herniation
types, fractures, fracture types [depressed or nondepressed], open
Table 1. Scoring system of the current Modified
Glasgow Coma Scale.4
Modified Glasgow Coma Scale Score
Motor activity
Normal gait, normal spinal reflexes 6
Hemiparesis, tetraparesis, or decerebrate activity 5
Recumbent, intermittent extensor rigidity 4
Recumbent, constant extensor rigidity 3
Recumbent, constant extensor rigidity with
opisthotonus
2




Normal pupillary light reflexes and vestibulo-ocular
reflex
6
Slow pupillary light reflexes and normal to reduced
vestibulo-ocular reflex
5
Bilateral unresponsive miosis with normal to reduced
vestibulo-ocular reflex
4
Pinpoint pupils with reduced to absent
vestibulo-ocular reflex
3
Unilateral, unresponsive mydriasis with
reduced to absent vestibulo-ocular reflex
2
Bilateral, unresponsive mydriasis with
reduced to absent vestibulo-ocular reflex
1
Level of consciousness
Occasional periods of alertness and responsive
to environment
6
Depression or delirium, capable of responding
but response may be inappropriate
5
Semicomatose, responsive to visual stimuli 4
Semicomatose, responsive to auditory stimuli 3
Semicomatose, responsive only to repeated
noxious stimuli
2
Comatose, unresponsive to repeated noxious stimuli 1
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or closed fractures, surgical decompression, or seizures). Chi-
square was used to test for association of binomial risk factors
with death by 48 hours or seizures. Mann-Whitney U-tests were
used to compare risk factors (MRI grade, intraparenchymal
lesion percentage, percentage of midline shift) between dogs that
were alive or dead at 48 hours and between dogs with and with-
out seizures. All tests were 2-sided and the significance level was
a = 0.05.
Results
A total of 50 dogs fulfilled the inclusion criteria. Of
these, 11 (22%) were intact females, 12 (24%) were
intact males, 17 (34%) were spayed females, and 10
(20%) were castrated males. The median age at presen-
tation was 3 years (range, 2 months to 12 years). The
median body weight was 8 kg (range, 0.9–45).
Breeds represented included crossbreed (n = 5), Toy
poodle (4), Yorkshire Terrier (3), Dachshund (2), Jack
Russell Terrier (2), Pomeranian (2), Labrador (2),
Hungarian Vizsla (2), Cavalier King Charles Spaniel
(2), Chihuahua (2), Lurcher (2), Staffordshire Bull Ter-
rier (2), West Highland White Terrier (1), Rhodesian
Ridgeback (1), Border Terrier (1), Dalmatian (1),
Golden Retriever (1), Cocker Spaniel (1), West High-
land White Terrier (1), Cairn Terrier (1), Labradoodle
(1), Bearded Collie (1), Great Dane (1), Miniature Bull
Terrier (1), Greyhound (1), Doberman (1), Tibetan
Spaniel (1), Miniature Schnauzer (1), Beagle (1), Lhasa
Apso (1), Weimaraner (1), and English Springer Span-
iel (1).
The most common cause of TBI was road traffic
accident (RTA) in 20 dogs (40%) followed by canine
attack in 9 dogs (18%), a fall in 9 dogs (18%), being
hit by an object in 8 dogs (16%), and kicked by a
horse in 4 dogs (8%).
The median MGCS at presentation was 16 (range,
8–18). All dogs were hospitalized and received stan-
dard treatment for stabilization after TBI.1,21 Two
dogs were presented in status epileptics and therefore
MGCS could not be assessed at presentation.
Imaging Findings
Median time interval between TBI and MRI was
1 day (range, <1 day to 14 days). Thirty-three dogs




Fig 1. Brain magnetic resonance imaging (MRI) of dogs with traumatic brain injury. Transverse T2-weighted images Fast Spin Echo
(A–F) showing the MRI grading system. (A) Grade I—normal parenchyma. (B) Grade II—lesions only affecting the cerebral hemisphere,
cerebellar parenchyma without midline shift or both. (C) Grade III—lesions only affecting the cerebral hemisphere, cerebellar paren-
chyma, or both and causing midline shift. (D) Grade IV—lesions affecting corpus callosum, thalamus, or basal nuclei with or without
any of the foregoing lesions of lesser grades. (E) Grade V—unilateral lesions in the brainstem with or without any of the foregoing
lesions of lesser grades. (F) Grade VI—bilateral lesions affecting the brainstem with or without any of the foregoing lesions of lesser
grades.
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was III (range, I-VI). Seventeen dogs presented with
grade I, 7 dogs presented with grade II, 4 dogs pre-
sented with grade III, 11 dogs presented with grade
IV, 8 dogs presented with grade V, and 3 dogs pre-
sented with grade VI MRI findings. The frequency of
agreement among radiologists was 82%. Twenty-eight
dogs had <25% of intraparenchymal lesions and 5
dogs had 25–50% of intraparenchymal lesions. No
dogs had >50% of intraparenchymal lesions.
A significant negative correlation was identified
between MGCS at presentation and MRI grade
(r = 0.63, P < .001) and for MGCS and size of intra-
parenchymal lesions (r = 0.58, P < .001).
The risk of developing seizures increased with sever-
ity of TBI. The presence of seizures was significantly
associated with higher size (>25%) of intraparenchy-
mal lesions (P = .0054). Twenty-three (46%) dogs had
skull fractures. Twelve of these 23 (52%) dogs devel-
oped seizures. Twelve dogs (52%) had open fractures
and 11 (48%) had closed fractures. Seventeen dogs
(74%) had depressed fractures.
Midline shift was present in 19 dogs (38%). The
median percentage of midline shift was 8.3% (range,
2.6–22.8). Brain herniation was present in 10 dogs
(20%). Eight dogs had brain HFS, 3 had FM, 3 had
CTH, and 2 had SFH.
Seizure occurrence was significantly associated with
HFS (P = .0122), CTH (P = .0172), and skull fractures
(P = .0279).
The MGCS score at presentation was significantly
lower in dogs with brain herniation than in those with-
out herniation (P = .0191), and specifically in dogs
with HFS than in those without HFS (P = .04).
Outcome
Eighteen dogs (36%) had seizures at some point
after TBI (median, 0.5 days; range, 0–427). Eight dogs
developed seizures immediately, 6 dogs developed early
seizures, and 4 dogs developed late onset seizures. A
total of 5 dogs exhibited recurrent seizures (10%) indi-
cating development of PTE. None of these dogs had
experience seizures before head trauma. The median
number of days before PTE onset was 119 (range,
0–427). Fifteen dogs with seizures were started on an-
tiepileptic medication: 11 dogs on phenobarbitone, 2
dogs on potassium bromide, 1 dog on phenobarbitone
and potassium bromide, and 1 dog on levetiracetam.
Antiepileptic medication was discontinued in 7 dogs
within a year after TBI because of the lack of seizure
activity. Three dogs were lost to follow-up. The
remaining 4 dogs were in the group with PTE. The
owner of 1 dog with PTE declined to start antiepileptic
medication because of the low frequency of epileptic
events (3 episodes per year). Three dogs were started
on prophylactic antiepileptic medication (phenobarbi-
tone) immediately after TBI and the medication was
discontinued in 2 dogs after 1 year because of lack of
seizure activity. The remaining dog developed severe
cluster seizures 3 months after TBI and was eutha-
nized.
Five dogs (10%) underwent surgical decompression.
The prevalence of seizures was higher in dogs that
underwent surgical decompression (4/5; 80%) com-
pared to dogs that did not undergo surgical decom-
pression (14/45; 31.1%; P = .0307). Two of these 4
dogs had seizures after TBI and before surgical inter-
vention. The other 2 remaining dogs with surgical
decompression developed late onset seizures.
Three dogs (6%) were dead (nonsurvivors) 48 hours
after TBI. Death at 48 hours was significantly associ-
ated with herniation (P < .001), HFS (P = .0135), FM
(P < .001), CTH (P = .0398), SFH (P = .0075), and
depressed fractures (P = .0128). The size of intraparen-
chymal lesions was significantly higher (>25%) in dogs
that were dead at 48 hours (P = .0420) compared to
those that were alive at 48 hours.
Forty-one dogs had follow-up at 3 months with a
median outcome scale score of 2 (range, 1–3). One
dog was euthanized at 4 months because of severe
neurologic signs. Forty-two dogs had follow-up at
6 months with a median score of 2 (range, 0–3).
Thirty-eight dogs had follow-up at 12 months with a
median score of 2 (range, 2–3). Thirty-five dogs had
follow-up at 24 months with a median score of 3
(range, 2–3).
A significant negative correlation was identified
between MRI grade and scores at 3 (r = 0.44,
P = .0027) and 6 months (r = 0.37, P = .0160;
Fig 2). A significant negative correlation was identified
between percentage of midline shift and outcome score
at 6 (r = 0.53, P = .0353), 12 (r = 0.56, P = .0291),
and 24 months (r = 0.81, P < .001). A significant
negative correlation was identified between size of in-
traparenchymal lesions and follow-up scores at 3
(r = 0.43, P = .0037), 6 (r = 0.49, P = .001), 12
(r = 0.47, P = .0027), and 24 months (r = 0.36,
P = .0332; Fig 3). A positive correlation was identified
between follow-up scores at 3 (r = 0.46, P = .0018)
and 6 (r = 0.32, P = .0403) months with MGCS at
presentation.
Follow-up scores at 3, 6, 12, and 24 months were
significantly lower in dogs that had brain herniation or
fractures (Fig 4). Follow-up scores in dogs that had
HFS were significantly lower at 6 and 12 months. Fol-
low-up scores in dogs that had CTH were significantly
lower at 6, 12, and 24 months. Follow-up scores in
dogs that had FM herniation were significantly lower
at 3 and 6 months. Follow-up scores in dogs that had
surgical decompression were significantly lower at 3, 6,
and 12 months.
Discussion
Traumatic brain injury is an important cause of
morbidity and mortality in dogs.2 In agreement with
previous studies in dogs, RTA was the most common
cause of TBI in our study.2,9,10
There is growing recognition that prediction of out-
come in humans after TBI based only on the Glasgow
coma scale is very limited.22 Recent studies have
focused on MRI findings as predictors of clinical out-
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come because of its high sensitivity for the detection of
nonhemorrhagic contusions, brainstem lesions, and
diffuse axonal injuries.17,18,23–26 MRI analysis and
grading reported in this study appear to have clinical
relevance because of their significant correlation with
outcome. This study used a grading system modified
from human medicine, where the severity and location
of the lesions were taken into account.19 Brainstem
Fig 2. Box and whisker diagram displaying follow-up scores at 3 months (A) and at 6 months (B) with magnetic resonance imaging
grade.
Fig 3. Box and whisker diagram displaying follow-up scores at 3 months (A), 6 months (B), 12 months (C), and 24 months (D) with
size of intraparenchymal lesions (IP).
Fig 4. Line graph of follow-up scores at 3, 6, 12, and 24 months in dogs with brain herniation and in dogs without brain herniation
(A). Line graph of follow-up scores at 3, 6, 12, and 24 months in dogs with skull fractures and in dogs without skull fractures (B).
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lesions have been associated with poor outcome in
humans with caudal and bilateral brainstem injuries
detected on MRI having the poorest prognosis.19,23,25
Similarly in this study, unilateral and bilateral brain-
stem lesions were respectively classified with the higher
MRI grade (grade V and VI) and had significant nega-
tive correlation with MGCS at presentation and fol-
low-up scores, which is consistent with previous
studies in humans.23,25
The findings of this study also are in agreement with
previous work in humans where poor outcome was sig-
nificantly associated with brain herniation, skull frac-
tures, and increased size of intraparenchymal lesions.17,27
Recent studies support the use of advanced MRI tech-
niques in human patients with TBI, including diffusion
tensor imaging and resting state functional MRI, which
may help to better define the type of injury (diffuse
axonal injury) and predict outcome.28–30 Functional
MRI was not performed in our study, but its use in veter-
inary medicine also may advance the ability to prognosti-
cate and should be considered in the future.
One of the limitations of using MRI is that usually it
is performed in referral centers and requires patients that
are hemodynamically stable enough to undergo general
anesthesia. This necessity could suggest that patients
that undergo MRI are more likely to survive and that
patients with severe TBI may not reach the referral cen-
ter. A recent study reported that the risk of developing
severe perianesthetic complications in dogs with intra-
cranial lesions was nonsignificant compared with dogs
without intracranial lesions and the overall severe com-
plication rate was considered low (1.3%).31 The ultimate
anesthesia management goal in dogs with intracranial
lesions is to maintain cerebral perfusion by controlling
factors that have an effect on cerebral blood flow. This
goal can be successful with the use of multimodal tech-
niques, which are beyond the scope of our study.31,32
The mean time of performing MRI in this study was
1 day after TBI, but the number of dogs with severe TBI
that did not reach our referral center is unknown.
Posttraumatic seizures can cause secondary brain
injury, contributing to morbidity and mortality.33 Pre-
vious studies have reported the incidence of epilepsy as
0.55–2% of all the dogs referred to veterinary hospi-
tals.34–36 Our study demonstrated that 10% of dogs
with TBI develop PTE. Therefore, we can consider
dogs with TBI to have a 5- to 18-fold increased risk of
developing epilepsy compared to the general hospital
population and based on the expected incidence of epi-
lepsy. These results are similar to a recent study in
which 6.6% of dogs with TBI developed PTE and had
an 11.6-fold increased risk of developing epilepsy com-
pared to the general hospital population.9 Another
recent study reported that late onset of seizures in dogs
after TBI is greater than early onset of seizures (6.8%
versus 3.5%).10 This finding differs from our study in
which the onset of immediate or early onset of seizures
was greater than late onset of seizures (28% versus
8%). Four of the 5 dogs that developed PTE did not
have any immediate or early onset of seizures. There-
fore, in contrast to what is reported in the human liter-
ature, the early onset of seizures after TBI in dogs
does not seem to be an important risk factor for devel-
opment of PTE.5
According to the 3rd edition of the guidelines of
management of TBI in humans,37 the use of antiepilep-
tic medication is indicated to decrease the incidence of
early posttraumatic seizures, but early posttraumatic
seizures have not been associated with poorer out-
come. In human medicine, the role of prophylactic an-
tiepileptic medication in moderate to severe TBI is still
debatable, but there are some recent studies that sup-
port their use.38,39 Randomized controlled double-
blinded trials may be necessary to investigate whether
treatment (such as prophylactic antiepileptic medica-
tion) of these cases with increased risk of developing
PTE can alter outcome.
This study is retrospective with heterogeneous
design, including different ages of patients, antiepilep-
tic treatments, and multiple forms of TBI (mild to
severe TBI). Therefore, these results should be vali-
dated with prospective and multicenter studies. An
additional limitation of this study is that outcome
assessment was not performed blindly, because some
information about the patient history was known.
However, the authors do not think this situation
affected the overall results of this study.
In summary, this study supports the prognostic
value of MRI in dogs with TBI. The MRI classifica-
tion proposed here could help identify dogs at higher
risk of poorer outcome, which may allow modification
of the management of these patients and assist in
informing owners about the prognosis for survival and
the possibility of developing PTE.
Footnotes
a 1.5 Tesla MR scanner, GE Signa, GE Medical System, Milwau-
kee, WI
b Multi-Hance, Bracco Imaging SpA or Gadovist, Bayer Schering
Pharma, Berlin, Germany
c Osirix version 4.1.2 DICOM viewer, Pixmeo SARL, Bernex,
Switzerland
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